Swissmedic receives grant from the Bill & Melinda Gates Foundation

Grant agreement signed to continue supporting regulatory authorities in low and middle-income countries for a further three years


On 27 March 2024, Swissmedic signed a new grant agreement with the Bill & Melinda Gates Foundation. Under the terms of this agreement, both parties commit to supporting regulatory authorities in low and middle-income countries for a further three years, thereby improving access to healthcare in the targeted regions and countries. This commitment is aligned with Swiss health foreign policy and contributes to the implementation of its priority action area “Access to medicine”.

The agreement between Swissmedic and the Bill & Melinda Gates Foundation is based on the Memorandum of Understanding (MoU) signed in January 2014 by the Foundation, the Federal Department of Home Affairs (FDHA) and the Federal Department of Foreign Affairs (FDFA) with the aim of strengthening the regulatory systems in low and middle-income countries, thereby improving and accelerating access to healthcare and medicines. Its focus is on countries in sub-Saharan Africa. The overall aim of the project is to bring high-quality, life-saving medicines to patients as quickly as possible.

Swissmedic signed its first grant agreement with the Foundation in December 2015. Since then, Swissmedic, the three parties to the MoU and the World Health Organization (WHO) have developed a support programme consisting of three main areas of engagement:

The renewal of the grant agreement is of great importance to Swissmedic. The activities and support efforts that are already underway can therefore continue to be implemented as part of the operational activities for the next agreement period.

Further information on this subject can be found via the following link:

Address for enquiries

Media Unit

+41 58 462 02 76